Bristol-Myers Squibb Strikes $350 Million Deal To End Hawaii's Plavix Lawsuit

Bristol-Myers Squibb & Co (NYSE:BMY) has agreed to wage $350 cardinal to the State of Hawaii to settee claims related to the medicine cause Plavix, an antiplatelet cause that prevents humor clots by keeping platelets successful the humor from coming unneurotic and making clots.
The agreement…

This communicative appeared connected benzinga.com, 2025-05-13 19:36:07.